Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle de Graaf

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|June 5, 2003
Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicinMichelle de Graaf, Herbert M Pinedo, Razi Quadir, et al.
Current Pharmaceutical Design|June 8, 2002
Beta-glucuronidase-mediated drug releaseMichelle de Graaf, Epie Boven, Hans W Scheeren, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Expression of scFvs and scFv fusion proteins in eukaryotic cellsMichelle de Graaf, Ida H van der Meulen-Muileman, Herbert M Pinedo, et al.
Biochemical Pharmacology|October 23, 2004
A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapyMichelle de Graaf, Tapio J Nevalainen, Hans W Scheeren, et al.
Human Gene Therapy|March 17, 2004
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion proteinMichelle de Graaf, Herbert M Pinedo, Dinja Oosterhoff, et al.
Cardiovascular Research|May 24, 2005
Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardinJohn van Tuyn, Shoshan Knaän-Shanzer, Marloes J M van de Watering, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|June 5, 2003
Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicinMichelle de Graaf, Herbert M Pinedo, Razi Quadir, et al.
Current Pharmaceutical Design|June 8, 2002
Beta-glucuronidase-mediated drug releaseMichelle de Graaf, Epie Boven, Hans W Scheeren, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Expression of scFvs and scFv fusion proteins in eukaryotic cellsMichelle de Graaf, Ida H van der Meulen-Muileman, Herbert M Pinedo, et al.
Biochemical Pharmacology|October 23, 2004
A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapyMichelle de Graaf, Tapio J Nevalainen, Hans W Scheeren, et al.
Human Gene Therapy|March 17, 2004
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion proteinMichelle de Graaf, Herbert M Pinedo, Dinja Oosterhoff, et al.
Cardiovascular Research|May 24, 2005
Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardinJohn van Tuyn, Shoshan Knaän-Shanzer, Marloes J M van de Watering, et al.
Pageof 1